NCT07723248
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07723248
Title A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1) (Himalayas-1)
Acronym Himalayas-1
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors ORIC Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
First Urology PSC RECRUITING Jeffersonville Indiana 40207 United States Details
Urology Specialists of the Carolinas - University Place RECRUITING Charlotte North Carolina 29464 United States Details
Gabrail Cancer Center Research RECRUITING Canton Ohio 44718 United States Details
Urology Clinics Of North Texas RECRUITING Dallas Texas 75231 United States Details
Urology Partners of North Texas (UPNT) RECRUITING Fort Worth Texas 76132 United States Details
Houston Metro Urology (HMU) RECRUITING Houston Texas 77027 United States Details
Summit Urology RECRUITING Murray Utah 84107 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field